Lazard Asset Management LLC Harmony Biosciences Holdings, Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 6,683 shares of HRMY stock, worth $227,622. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,683
Previous 6,689
0.09%
Holding current value
$227,622
Previous $201,000
32.34%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.1MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$382 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$118 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$88.8 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$65.7 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.02B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...